New COE Enables a Patient-Centric Focus on Building and Driving an Optimal Patient Services Strategy
Upcoming Webinar “Developing Innovative, Patient-centric Services Using the Holistic Patient Journey” Outlines Ways to Design Optimized Patient Support Services
Waltham, MA, March 22, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a Patient Services Center of Excellence (COE) that offers life sciences companies data-driven insights, strategy and solutions to power patient-centric support services. Developing and executing high-impact Patient Support…
Waltham, MA, March 21, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has launched the TGaS Advisors’ Agency Optimization Benchmark. The new benchmark helps life sciences companies understand how their utilization of agencies compares to industry peers.
Drawing upon proprietary data collected from the TGaS Member Network, the Agency Optimization Benchmark provides a detailed comparative assessment for brand teams and commercial operations leaders in areas such as:
Number of agencies utilized
New COE Provides Insights from Stakeholder Perceptions of a Brand’s Equity and Trajectory
Upcoming Webinar “Far from Routine: Performance Tracking as a Source of Powerful Insight” Maps Out Ways to Proactively Translate Tracker Insights to Action
Waltham, MA, March 16, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the creation of Trinity Performance Tracking, a new Center of Excellence (COE) that focuses on a comprehensive approach to stakeholder perception tracking and integrates primary and…
Upcoming Webinar “Confident Contracting: Optimize and Accelerate Key Decisions with Tech-Enabled Impact Projections” Pinpoints Ways to Streamline the Contracting Process by Forecasting the Impact of Individual Contract Strategies
Waltham, MA, March 1, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Trinity Contract Analytics, an offering that enhances U.S. payer and provider contract strategy decisions with cloud-based modeling, scenario planning and analytics. Though contracting is an incredibly vital piece of a life sciences company’s U.S.…
New Thought Leadership Paper Available Now from Trinity Life Sciences
Waltham, MA, February 7, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, releases a white paper entitled Global Market Access Trends: 2022 Edition that identifies the five key market access trends that life sciences executives should understand to ensure their organizations are prepared for the year ahead.
Results from a survey conducted by Trinity Life Sciences in late 2022 using a sample of 11 U.S.…
San Francisco, CA – 41st Annual J.P. Morgan Healthcare Conference, January 10, 2023 – Trinity Life Sciences, a global leader in life sciences solutions, and Havas Health & You (HHY&Y), the world’s largest global health and wellness network and part of Havas Group, a Vivendi (VIV) business, today announced a strategic partnership that will allow both companies to offer cohesive end-to-end commercial solutions to the life sciences industry. The partnership includes Havas Health & You taking a minority investment in…
Waltham, MA, December 14, 2022 – Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Paul R. Lucchese as General Counsel and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s Chief Financial Officer and Head of Corporate Operations. He will be responsible for leading Trinity’s legal operations and global compliance activities.
Mr. Lucchese has extensive experience as a General Counsel in high-growth technology-forward organizations including Aspect Software, Candela Corporation,…
“Cracking the Code of the Access Landscape in China: Analysis of the 2021 NRDL Update” Available Now from Trinity Life Sciences
Waltham, MA, December 8, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that inclusion on the National Reimbursement Drug List (NRDL) offers substantial opportunities for innovative, clinically differentiated therapies in China despite steep price reductions. According to a new white paper entitled Cracking the Code of the Access Landscape in China: Analysis of…
Waltham, MA, November 30, 2022 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know To Be Prepared for 2023” and its podcast episode “What Leaders In Life Sciences Need To Know To Be Prepared for 2023” based on highlights presented at the TGaS Advisors’ 2022 Fall Client Summit. The TGaS 2022 Fall Client Summit was held in October at the W Hotel Philadelphia with nearly…
New E-book “Successfully Navigating the Sea of Competitive Intelligence in Life Sciences” Illustrates How Companies are Handling the Volume and Velocity of Data
Waltham, MA, November 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, sees competitive intelligence (CI) leaders in life sciences moving beyond data mining and monitoring to deliver accurate, robust insights. As there is more information becoming available at an ever-increasing pace, it has become more difficult to sift through and find…